A drug derived from olive oil has shown promising results in slowing down the progression of the deadly brain cancer glioblastoma. A recent trial conducted by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research involving 54 patients with recurrent glioblastoma and other advanced solid tumors revealed that a drug made from oleic acid, a component naturally found in olive oil, had a significant impact. Results indicated that 24% of the patients with glioblastoma responded well to the treatment, with one experiencing an exceptional response lasting over three years. The drug, known as 2-OHOA, disrupts abnormal growth signals in cancer cells, potentially halting the disease’s advancement. Glioblastoma affects 3,200 individuals in the UK annually and has a grim prognosis, making this breakthrough a beacon of hope for patients battling this aggressive form of brain cancer.
Olive Oil Derivative Shows Promise in Glioblastoma Treatment Study
Date:
Updated: [falahcoin_post_modified_date]